Your daily source for trading strategies, tech news, and politically incorrect humor.
Hey there, Bullets Fans –
Your Morning Bullets Brief Updates are here! And that means trivia is, too.
In what year did the Dow Jones Industrial Average have its best January 22 in history?
Think you know the answer? You can check it in the closing area down below!
Image Source: Morning Bullets
Though Dow futures were pointing to losses this morning, all three major indexes are up for the week so far, with the Dow Jones Industrial Average gaining 1.2%, the S&P 500 gaining over 2.5%, and the Nasdaq soaring 4%.
Meanwhile, IBM saw its shares plummet 7% in the premarket following a disappointing earnings report. Intel also saw its shares dip 4%.
And, in his latest round of executive orders, President Joe Biden is signing documents that would provide additional food assistance and bolster the minimum wage.
Fauci has also shared that the current vaccines might not actually be as helpful in combating newer versions of the virus (more on that, below).
And Senate Minority leader Mitch McConnell wants to push back former President Donald Trump’s impeachment trial until next month, so that Trump may have additional time to prepare.
Other News That Matters To You:
This is about to trump them all!
Image Source: Reuters
Dr. Anthony Fauci warned yesterday that the current vaccines might not effectively combat the newer mutations of the virus, which appear to be more contagious, though not more deadly, than the original strain.
For instance, the mutated version that emerged in South Africa appears to be unaffected by the current treatments.
“Furthermore, 501Y.V2 [the strain in South Africa] shows substantial or complete escape from neutralising antibodies in [virus] convalescent plasma,” researchers said.
Even so, Fauci says it’s just as important for as many people as possible to receive the vaccine, to prevent further mutation and spread.
“Bottom line: We’re paying very close attention to it,” Fauci said. “There are alternative plans if we ever have to modify the vaccine. That’s not something that is a very onerous thing, we can do that given the platforms we have.”
More Headline You Need To Read: